Aktie 300158 SHANXI ZHENDONG PHARMACEUTICAL CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shanxi Zhendong Pharmaceutical Co.,Ltd

Aktien

300158

CNE100000YR9

300158

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 08.05.2024 		% 5 Tage % 1. Jan.
5,06 CNY +1,00 % Intraday Chart für Shanxi Zhendong Pharmaceutical Co.,Ltd +7,66 % -25,04 %
22.04. Shanxi Zhendong Pharmaceutical Co.,Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024 CI
22.04. Shanxi Zhendong Pharmaceutical Co.,Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024.
Shanxi Zhendong Pharmaceutical Co.,Ltd agreed to acquire additional 53.985% stake in Guangdong Longchuangji Pharmaceutical Co., Ltd. from Guangdong Qiangji Pharmaceutical Co., Ltd.
Guangdong Longchuangji Pharmaceutical Co., Ltd. announced that it has received CNY 30 million in funding from Shanxi Zhendong Pharmaceutical Co.,Ltd
Shanxi Zhendong Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.
Shanxi Zhendong Pharmaceutical Co.,Ltd authorizes a Buyback Plan.
Guangdong Longchuangji Pharmaceutical Co., Ltd. announced that it expects to receive CNY 30 million in funding from Shanxi Zhendong Pharmaceutical Co.,Ltd
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
FountainVest Capital Partners Fund IV, L.P., a fund managed by Fountain Vest Capital Partners GP4 Ltd. completed the aquistion of Beijing Zhendong Langdi Pharmaceutical Co., Ltd. from Shanxi Zhendong Pharmaceutical Co.,Ltd.
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Shanxi Zhendong Pharmaceutical Co.,Ltd(XSEC:300158) added to S&P Global BMI Index
Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Zhongtai Asset Management Plan No. 45 Single Asset Management Plan, managed by Zhongtai Securities Asset Management Co.,Ltd. completed the acquisition of a 5% stake in Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE : 300158) from Shanxi Zhendong Health Industry Group Co., Ltd.
Zhongtai Asset Management Plan No. 45 Single Asset Management Plan, managed by Zhongtai Securities Asset Management Co.,Ltd. signed a share transfer agreement to acquire a 5% stake in Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE : 300158) from Shanxi Zhendong Health Industry Group Co., Ltd. for approximately CNY 340 million.
Shanxi Zhendong Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 09 May 2022
Shanxi Zhendong Pharmaceutical Co.,Ltd Approves 2021 Profit Distribution Plan
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300158 Aktie
  4. Nachrichten Shanxi Zhendong Pharmaceutical Co.,Ltd
  5. Andere Sprachen